Loading...
Loading...
CDC PLACES (2023, crude) estimates 12% of adults in Chicago have diagnosed diabetes — about even with the U.S. 12% figure. Census population 2,693,976. Illinois Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Chicago clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Chicago storefront.
Build Your Biologic Treatment Center in Chicago, IL for clinics & physicians. Start or expand your biologi… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 19.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 12% of adults in Chicago have diagnosed diabetes — about even with the U.S. 12% figure. Together those PLACES numbers are why a city of 1M+ still needs separate PRP and CTP protocols. biologic treatment center inventory is national; utilization is J6-local.
National Build Your Biologic Treatment Center notes (how the product actually works)J6 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Chicago is 12% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, J6 articles mapped. 13.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 12% of adults — about even with the U.S. 12% figure. Obesity is 32.6%; arthritis is 19.6%. That is place-level BRFSS modeling, not a clinic census and not a Chicago trial.
Often yes, which is the point of vendor consolidation. Keep DME delivery tickets and HCT/P lot files separate so a Illinois audit trail stays clean.
We source from FDA-registered banks. Bank location is not the same as Hawk Medical’s distribution address, and it is not a Chicago clinic. Ask for the bank’s registration and AATB status on the SKU you want.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Illinois.
If you operate in Illinois and another MAC state, say it on the first call. J6 will not port 1:1. We would rather split utilization than watch a sister clinic copy Chicago tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Chicago, IL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Chicago is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Chicago — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
Illinois Part B wound biologics follow this contractor (siblings: MN, WI). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Chicago. Useful for joint-program math; still needs a diagnosis and privileging.
No Chicago storefront. Joe Bradley is an active practice owner. biologic treatment center stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.